Abrdn Healthcare Opportunities Fund (THQ) Stock Price & Analysis
Abrdn Healthcare Opportunities Fund (THQ) closed at USD 18.38 on Friday, October 23, 2026, down 1.34% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 18.63; the Oct 23, 2026 session ranged USD 18.29–18.74 on volume of 89,224 shares. Market capitalization is $761.62M, with a 52-week range of USD 16.28–20.39 (NYQ). Source: Nexqual, retrieved October 24, 2026 at 08:30 UTC.
Also available as compact Markdown for AI agents: nexqual.com/THQ.md
Key facts (THQ)
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $11K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: None.
- Total return with dividends: 1Y +13.3% vs S&P 500 +13.4%; 5Y +17.8% vs S&P 500 +76.9%.
Insider purchases (SEC Form 4, open-market, last ~7 months) (THQ)
1 purchase, $11K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-07-16 | Mahai Chris Lavictoire | Director | 568 | $11K | 18.49 | Too little history (no open-market trades in 2023–2025) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (THQ)
Consensus None.
Total return (dividends reinvested) (THQ)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +13.3% | +17.8% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +13.3% | +3.3% |
| Volatility (annualized) | 18.7% | 20.7% |
| Max drawdown | -16.7% (Jan 2026→Mar 2026) | -32.2% (Dec 2021→Oct 2023) |
THQ analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 08:30 UTC)
| Price | USD 18.38 |
|---|---|
| Change | ▼ 1.34% (down) |
| Previous Close | USD 18.63 |
| Open | USD 18.65 |
| Day Range | USD 18.29 – 18.74 |
| 52-Week Range | USD 16.28 – 20.39 |
| Volume | 89,224 shares |
| Market Cap | $761.62M |
| Exchange | NYQ |
Technical Analysis (THQ)
Nexqual's technical model rates THQ "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 24, 2026 at 08:30 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.27 (neutral) |
| vs SMA50 | Below (USD 18.86) |
| MACD | -0.07 (negative) |
Analyst Ratings (THQ)
Wall Street analysts rate THQ "None", per Nexqual as of October 24, 2026 at 08:30 UTC.
| Consensus Rating | None |
|---|
Earnings (THQ)
Source: Nexqual, October 24, 2026 at 08:30 UTC.
Financials & Fundamentals (THQ)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, October 24, 2026 at 08:30 UTC.
Ownership (THQ)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +19.63% |
| Shares Outstanding | 41.44M |
| Short % of Float | +0.15% |
Source: Nexqual, October 24, 2026 at 08:30 UTC.
Leadership (THQ)
Abrdn Healthcare Opportunities Fund is led by Daniel R. Omstead M.S, President and Trustee, per Nexqual as of October 24, 2026 at 08:30 UTC.
| President and Trustee | Daniel R. Omstead M.S |
|---|
Major Backers & Investors (THQ)
Notable institutional backers of Abrdn Healthcare Opportunities Fund include Morgan Stanley, Royal Bank of Canada, Raymond James Financial, Inc., according to Nexqual as of October 24, 2026 at 08:30 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 3.47% |
| Royal Bank of Canada | 2.68% |
| Raymond James Financial, Inc. | 1.75% |
| Heron Bay Capital Management | 1.36% |
| Penserra Capital Management LLC | 1.12% |
| Amplify ETF Trust-Amplify CEF High Income ETF | 1.12% |
| LPL Financial LLC | 0.84% |
| Ameriprise Financial, Inc. | 0.49% |
Source: Nexqual, October 24, 2026 at 08:30 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BXSL | Blackstone Secured Lending Fund | USD 23.33 | ▼ 2.43% |
| VCTR | Victory Capital Holdings, Inc. | USD 107.6 | ▲ 0.2% |
| PDI | PIMCO Dynamic Income Fund | USD 14.31 | ▲ 0.07% |
| AMG | Affiliated Managers Group, Inc. | USD 383.42 | ▼ 3.06% |
| SEIC | SEI Investments Company | USD 102.3 | ▼ 2.11% |
| IVZ | Invesco Ltd | USD 28.06 | ▼ 2.54% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 08:30 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt